Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LOSARTAN POTASSIUM
- Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan
- Ethosomal Gel Bearing Losartan 5% for Keloid Treatment
- Losartan and Memory
- Azilsartan in Patients With Diabetic Kidney Disease and Hypertension
- Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
- Losartan in Prevention of Radiation-Induced Heart Failure
- Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropaties: a Cross-over Randomized Clinical Trial
- Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled Trial
- Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting Conditions
- Effect of Losartan or Eprosartan on Fructose Hyperuricemia
- Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
- Losartan for Improved Vascular Endothelial Function After Preeclampsia
- NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer
- Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients
- Losartan to Improve Hip Microfracture
- Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)
- Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients
- Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients
- Losartan and Emotional Memory
- PDD in Type 2 Diabetes w/wo Diastolic Dysfunction
- The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD
- Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern
- Losartan for the Treatment of Pediatric NAFLD
- A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions
- The Effect of Losartan on Emotional Processing in Healthy Volunteers
- An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)
- Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension
- Influence of Aliskiren on Albuminuria After Kidney Transplantation
- Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis
- Losartan in Decompensated Heart Failure
- Diurnal Variation in Hypertensive Stroke Patients
- Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD
- A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects
- INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria
- A Drug-Drug Interaction Study of Losartan and PA21
- MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)
- MK-0954E Study in Participants With Hypertension (MK-0954E-357)
- MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)
- Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
- Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Hum
- Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Hum
- Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fed Condition
- Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting Condition
- Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed Conditions
- Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions
- Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions
- Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions
- Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers
- Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)
- Olmesartan Comparison to Losartan in Hypertensive Subjects
- The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)
- Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria
- MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension
- A Study to Investigate the Antihypertensive Efficacy of MK0954
- A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)
- A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)
- Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer
- Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis
- Olmesartan Medoxomil Versus Losartan in Patients With Hypertension
- Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension
- Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)
- The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)
- Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?
- Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)
- A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients
- Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial
- Antihypertensive Response to Losartan and Genetic Polymorphisms
- An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))
- VA NEPHRON-D: Diabetes iN Nephropathy Study
- LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)
- Prevention of Diabetes and Hypertension
- An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essent
- A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)
- Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome--Pediatric Heart Network
- Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study
- Improving Outcomes in Patients With Kidney Disease Due to Diabetes
- Obese Hypertension Study (0954-315)
- AVE7688 in Patients With Mild to Moderate Blood Pressure
- Treatment of Supine Hypertension in Autonomic Failure
- A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin
- Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)
- Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)
- ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)
- Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)
Clinical trials list
click for details